Christina Larkin
2018
In 2018, Christina Larkin earned a total compensation of $533.8K as Chief Operating Officer at Spero Therapeutics, a 56% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $148,225 |
|---|---|
| Salary | $385,000 |
| Other | $574 |
| Total | $533,799 |
Larkin received $385K in salary, accounting for 72% of the total pay in 2018.
Larkin also received $148.2K in non-equity incentive plan and $574 in other compensation.
Rankings
In 2018, Christina Larkin's compensation ranked 11,663rd out of 14,244 executives tracked by ExecPay. In other words, Larkin earned more than 18.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,663 out of 14,244 | 18th |
Division Manufacturing | 4,703 out of 5,759 | 18th |
Major group Chemicals And Allied Products | 1,777 out of 2,122 | 16th |
Industry group Drugs | 1,513 out of 1,811 | 17th |
Industry Pharmaceutical Preparations | 1,161 out of 1,385 | 16th |
Source: SEC filing on September 30, 2020.
Larkin's colleagues
We found three more compensation records of executives who worked with Christina Larkin at Spero Therapeutics in 2018.